NAVIDEA BIOPHARMACEUTICALS, INC. Amortization of Intangible Assets
NAVIDEA BIOPHARMACEUTICALS, INC. reported Amortization of Intangible Assets of $47.59 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2023-03-27
- NAVIDEA BIOPHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2022 was $47.59K, a 18.53% increase from fiscal 2021.
- NAVIDEA BIOPHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2021 was $40.15K, a 10.11% increase from fiscal 2020.
- NAVIDEA BIOPHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2020 was $36.46K, a 11.81% decline from fiscal 2019.
- NAVIDEA BIOPHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2019 was $41.35K, a 39.38% increase from fiscal 2018.
| Period end | Amortization of Intangible Assets 12 month |
|---|---|
| 2022-12-31 | $47.59K 10-K · filed 2023-03-27 |
| 2021-12-31 | $40.15K 10-K · filed 2023-03-27 |
| 2020-12-31 | $36.46K 10-K · filed 2022-03-28 |
| 2019-12-31 | $41.35K 10-K · filed 2021-03-26 |
| 2018-12-31 | $29.66K 10-K · filed 2020-03-18 |
| 2017-12-31 | $22.25K 10-K · filed 2019-03-15 |
| 2016-12-31 | $5.19K 10-K · filed 2018-03-15 |
| 2015-12-31 | $8.95K 10-K · filed 2018-03-15 |
| 2014-12-31 | $12.28K 8-K · filed 2017-12-15 |
| 2013-12-31 | $3.88K 10-K · filed 2016-03-23 |
| 2012-12-31 | $1.40K 10-K · filed 2015-03-16 |
| 2011-12-31 | $1.25K 10-K · filed 2014-03-14 |
| 2010-12-31 | $8.00K 10-K/A · filed 2013-03-21 |
| 2009-12-31 | $131.05K 10-K · filed 2012-03-07 |